Novartis has made a dramatic return to the Huntington's disease therapy stage by licensing a candidate from PTC Therapeutics for a whopping $1 billion upfront. The deal – which has a potential total ...

Abstract: In this technical note, an adaptive model-predictive control (MPC) is proposed for a class of discrete-time linear systems with constant parametric uncertainties and control constraint. The ...